N/A
N=80
Acupuncture Using Yamamoto's Method for the Treatment of Acute Nonspecific Low Back Pain
Low Back Pain
Bottom Line
View on ClinicalTrials.gov: NCT01124955 ↗Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Jun 2011
Primary outcome: Primary: Pain Assessed on a 10-point Numeric Pain Scale — 6.55; 6.68; 4.63; 5.13 cm
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Acupuncture (Other); Non-penetrating acupuncture (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Federal University of São Paulo
- Primary completion
- Jun 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Assessed on a 10-point Numeric Pain Scale |
6.55; 6.68; 4.63; 5.13; 3.83; 4.4 | — |
| SECONDARY Roland-Morris Disability Questionnaire (RM) |
14.9; 14.6; 10.3; 12.4; 8.1; 10.2 | 0,05 sig |
| SECONDARY Quality of Life Assessed on the SF-36 |
46.4; 55.8; 58.5; 60.6; 68.8; 66.6 | — |
| SECONDARY Likert Improvement Assessment Scale |
1.6; 2.15; 1.6; 2.0; 1.67; 2.27 | — |
| SECONDARY Number of Anti-inflammatory Tablets Taken |
1.5; 2.6; 1.9; 4.2; 1.3; 3.3 | — |
Summary
The aim of the present study is to assess the effectiveness of acupuncture using Yamamoto's method for the treatment of ANLBP using the following outcomes:pain,functional capacity,quality of life and number of 50 mg sodium diclofenac pills taken per day.
Eligibility Criteria
Inclusion Criteria
- Male or female
- Aged 18 to 65 years
- Seeking medical assistance for nonspecific low-back pain
- Score of 4 to 8 cm on the pain scale (0 to 10 cm)
- Agreed to participate and signed term of informed consent
Exclusion Criteria
- Patients with a diagnostic investigation of secondary causes as spondyloarthropathy, infection, tumor or fracture
- Sciatica lumbar pain
- Previous surgery on spinal column
- Litigation
- Having changed physical activity or underwent acupuncture or physical therapy in previous three months,
- Having previously undergone scalp acupuncture
- Pregnancy
- Contraindication for anti-inflammatory agents
Data sourced from ClinicalTrials.gov (NCT01124955). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.